Alliance Pharma PLC (FRA:DVL) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ...

By Yahoo! Finance | Oct 1, 2024 at 03:04 AM EST

The company is focusing on expanding MacuShield and Hydromol brands in new markets by building clinician awareness gradually. Priorities include addressing issues like the buy box problem for Amberen in the US and ensuring supply security for Nizoral.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.